Article Details
Retrieved on: 2021-08-26 19:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
India-based Gennova Biopharmaceuticals Ltd. confirmed it had been granted authorization to conduct phase 2/3 clinical trials for the mRNA-based COVID-19 ...
Article found on: www.precisionvaccinations.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here